|
|
|
| December 2001, Volume 25, Supplement 4, Pages S12-S15 |
| Table of contents Previous Abstract Next Article PDF |
 |
| Paper |
| Sibutramine in clinical practice |
|
| N Finer |
|
The Luton and Dunstable Hospital NHS Trust, Luton, UK
|
|
Correspondence to: N Finer, Luton and Dunstable Hospital NHS Trust, Lewsey Road, Luton, Beds, LU4 OD2, UK. E-mail: Nick.Finer@ldh-tr.anglox.nhs.uk
|
|
| Abstract |
| The role of sibutramine as an effective adjunct to diet and exercise in weight management programmes has been proven in clinical trials. Although the reality of managing obesity in clinical practice is very different from that of a controlled clinical trial, there is good evidence that sibutramine is an easy-to-use and highly effective additional therapy when used in everyday practice to manage obesity and its complications. It is possible to predict which patients will respond well to sibutramine treatment, and to modify programmes and support to ensure the best outcome for patients, whatever their clinical circumstances. International Journal of Obesity (2001) 25, Suppl 4, S12-S15. |
|
| Keywords |
| sibutramine; clinical issues; predicting response; initial weight loss |
|
|
|
|
|
|
| December 2001, Volume 25, Supplement 4, Pages S12-S15 |
| Table of contents Previous Abstract Next Article PDF |
|
|
